23 févr. 2017 - > Health Economic analysis 2 Conclusion: screening gastroesophageal reflux patients with Cytosponge and confirmation by endoscopy is an cost-effective strategy.
Description:
Funding This study was supported by the National Institutes of Health/National Cancer Institute grants U01 CA 199336 and CA 152926 (C.H., J.I., and G.L.), and R01 CA 140574 (C.H.). The National Cancer Institute played no active role in the study design, analysis, or writing of the publication.Ajouté au bande de temps:
Date:
23 févr. 2017
Maintenaint
~ Il y a 8 ans et 3 mois